Related Experiment Video
Updated: Aug 8, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression, and blocks myeloid differentiation
Aleksandra Azevedo1, Adam Leckenby1, Rachael Nicholson1
1Division of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Abstract:
Expression of RUNX1::RUNX1T1 (also known as RUNX1::ETO) is frequently observed in acute myeloid leukemia (AML) and has been shown to block myeloid development. Although several studies have shown RUNX1::RUNX1T1 transcriptional deregulation, the proteome in human hematopoietic stem and progenitor cells (HSPCs) is poorly characterized. Using mass spectrometry, we show that expression of RUNX1::RUNX1T1 in human HSPCs was linked to differential expression of 257 proteins, including CCAAT/enhancer-binding protein beta (C/EBPβ) downregulation. Consistent with this observation, although CEBPB mRNA is generally overexpressed in AML, patients with t(8;21) have comparatively low CEBPB expression. We show in human HSPCs that ectopic expression of C/EBPβ can promote proliferation of myeloid cells. Conversely, short hairpin RNA-mediated knockdown of C/EBPβ inhibited the growth of normal human myeloid cells; however, it promoted the growth of cells expressing RUNX1::RUNX1T1. C/EBPβ also influenced differentiation, with ectopic expression promoting monocyte development, whereas reduced expression favored granulocyte differentiation, which in turn suggests that C/EBPβ expression may act as a lineage discriminator for these myeloid cell types. In summary, our data reveal how RUNX1::RUNX1T1 drives deregulation of the HSPC proteome and suggest a mechanism by which RUNX1::RUNX1T1 expression contributes to leukemia development, including C/EBPβ, which itself affects normal myeloid development.
Insights
RUNX1::RUNX1T1 fusion protein in acute myeloid leukemia (AML) disrupts myeloid development by altering the proteome, specifically downregulating CCAAT/enhancer-binding protein beta (C/EBPβ). This impacts myeloid cell proliferation and differentiation, contributing to leukemia pathogenesis.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Research
Background:
- Acute myeloid leukemia (AML) is often associated with the RUNX1::RUNX1T1 fusion gene, which impairs myeloid development.
- The proteome alterations in human hematopoietic stem and progenitor cells (HSPCs) driven by RUNX1::RUNX1T1 are not well understood.
Purpose of the Study:
- To investigate the proteomic changes in human HSPCs expressing RUNX1::RUNX1T1.
- To elucidate the role of CCAAT/enhancer-binding protein beta (C/EBPβ) in RUNX1::RUNX1T1-mediated myeloid deregulation and leukemia development.
Main Methods:
- Mass spectrometry was employed to analyze the proteome of human HSPCs with RUNX1::RUNX1T1 expression.
- Functional studies involved ectopic expression and short hairpin RNA (shRNA)-mediated knockdown of C/EBPβ in human myeloid cells.
Main Results:
- RUNX1::RUNX1T1 expression in HSPCs led to differential expression of 257 proteins, including significant downregulation of C/EBPβ.
- Ectopic C/EBPβ enhanced myeloid cell proliferation, while C/EBPβ knockdown inhibited normal myeloid growth but promoted growth in RUNX1::RUNX1T1-expressing cells.
- C/EBPβ influenced myeloid lineage commitment, with its overexpression favoring monocyte development and reduced expression favoring granulocyte differentiation.
Conclusions:
- RUNX1::RUNX1T1 significantly alters the HSPC proteome, with C/EBPβ downregulation being a key event.
- C/EBPβ plays a critical role in regulating myeloid cell proliferation and differentiation, and its dysregulation by RUNX1::RUNX1T1 contributes to AML pathogenesis.
- C/EBPβ acts as a potential lineage discriminator in myeloid development, offering insights into leukemia mechanisms.
Related Concept Videos
Master Transcription Regulators
TGF - β Signaling Pathway
Regulation of Expression at Multiple Steps
Canonical Wnt Signaling Pathway
Cell Specific Gene Expression
RNA Polymerase II Accessory Proteins

